Hong Liang
CIK 1754627 · SVP, Discovery Medicine · last filed 2020-04-06
Hong Liang is a SVP, Discovery Medicine who has filed 8 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing shows the insider sold $169.4K of KOD on Apr 6, 2020. Across all open-market trades the lifetime net is −$518.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.55M
1
8
-$518.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KOD | SVP, Discovery Medicine | 130,166 | $42.64 | $5.55M | -$518.3K | 8 | 2020-04-06 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-06 | KOD | Sell (S) | −4,000 | -$169.4K | EDGAR |
| 2020-03-30 | KOD | Sell (S) | −4,000 | -$191.1K | EDGAR |
| 2020-03-23 | KOD | Sell (S) | −4,000 | -$157.8K | EDGAR |
| 2020-01-02 | KOD | Grant (A) | — | $0 | EDGAR |
| 2019-12-04 | KOD | Exer (M) | +42,166 | $44.1K | EDGAR |
| 2019-07-18 | KOD | Grant (A) | — | $0 | EDGAR |
| 2019-02-08 | KOD | Exer (M) | +80,000 | $83.2K | EDGAR |
| 2018-10-05 | KOD | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.